Myopia progression: can we control it?

1 March 2013
Volume 14, Issue 1

Should we be attempting to control myopia progression in a clinical setting? And,if so, what are the options?

Introduction

Many more children suffer from myopia than was the case 50 years ago: in parts of Asia, over 70% of children are now myopic and require some form of refractive correction to see clearly. A vast literature on possible causes of myopia and methods for controlling myopia progression has built up over the years and, until recently, distinguishing between hypothesis and real evidence has posed a significant challenge. Recent clinical trials of a variety of methods for controlling myopia progression have shown encouraging results and several methods are becoming commercially available. This article addresses the question: should we now be attempting to control myopia progression in a clinical setting? If so, what are the options?

Sign in to continue

Forgotten password?
Register

Not already a member of The College?

Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.

Related further reading

With half the world's population estimated to be myopic by 2050, Olivier Denève, our Head of Policy and Public Affairs, asks how we can explain the risks and benefits to patients.

Heart attacks transiently increase in number when the clocks go forward. Diabetic retinopathy and glaucoma can interfere with the body’s sleep-wake cycles. Becky McCall examines the relationship between the eye and sleep.

Here we summarise three research papers from a recent issue of Optometry in Practice.